News
Belite Bio (NASDAQ:BLTE) is a small company with multiple phase 3 trials targeting retinal degenerative eye diseases. The stock looks interesting, with late-stage trials...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Victor Dergunov is an independent investor and author with 20 years experience. He preaches diversification and shares investment...
News
This article was written by Follow I aim to invest in companies with perfect qualitative attributes, buy them at an attractive price based on...
News
This article was written by Follow Author and entrepreneur. My articles typically cover macroeconomic trends, portfolio strategy, value investing, and behavioral finance. I like...
News
Dear Quentin, My husband and I have been together for six years, and we have made some good and, yes, some bad financial choices...
News
To buy or not to buy, that is the question many people are contemplating in the current real estate market and economic conditions. Regardless...
News
One of the most interesting stocks (and companies) right now is without much doubt Nvidia Corporation (NASDAQ:NVDA), as it seems to be a stock...
News
Before making a lifelong commitment, we determine our compatibility with a potential mate by vetting their personality, intelligence, moral compass, family, and career. Do...
News
Earnings of Heritage Commerce Corp (NASDAQ:HTBK) will most probably continue on an uptrend this year thanks to decent loan growth. I’m expecting the company...
News
Sure, you can buy dad a bottle of his beloved booze for Father’s Day. But why stop there? For the big holiday, which falls...
News
Author’s note: This article was released to CEF/ETF Income Laboratory members on May 22nd. I’ve covered the iShares Preferred and Income Securities ETF (NASDAQ:PFF)...
News
Pyxis Oncology (NASDAQ:PYXS) is a good speculative biotech play to look into. The reason why I state that is because even though it deploys...
News
There is no U.S. state, metropolitan area or county where a minimum-wage worker clocking 40 hours a week could reasonably afford a “modest two-bedroom...
